AKT1 and triple-negative breast carcinoma: In addition, it shows the therapeutic potential of PIP5K1α inhibitor ISA-2011B, as it specifically induces apoptosis and inhibits metastasis by blocking the elevated PI3K/AKT pathway in triple-negative breast cancer.